Kate Beecher Matthews (she/her)

🎉 Exciting news! Our paper "ROS1 IHC as a potential predictive biomarker in breast cancer" has been chosen as the cover feature for this issue of @Histo_Journal ! 🧬💥

To read our paper ➡️ doi.org/10.1111/his....

#BreastCancer #Pathology #Histopathology #UQCCR

Brisbane Breast Bank - Lobular breast cancer research The Brisbane Breast Bank is a repository for donated breast cancer samples. The researchers in our team study a range of different types of breast cancers, including lobular breast cancer.

Lobular #breastcancer is under-recognised & under-researched — we're working to change that.

Support our #research at UQ & the Brisbane Breast Bank to improve detection & treatment💗

🔗 www.justgiving.com/campaign/bri...

#LobularBreastCancer #ILC #WomensHealth #UQCCR

LBCA is offering travel scholarship grants for advocates interested in Invasive Lobular Carcinoma (ILC) education to attend the 2025 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas, December 9-12, 2025. Deadline to apply is Monday, July 21st: tinyurl.com/LBCATravelGr...

Our lab just loves working extra hard on a Friday 🧑‍🔬🙌😂!!
@breast-lab.bsky.social @amymccart.bsky.social @kate-beecher.bsky.social

🎤A/Prof @amymccart.bsky.social officially opened the Herston Breast Cancer Research Network at #UQCCR
An exciting step forward in strengthening collaboration across research, clinical care, & innovation in #breastcancer💗🧬#HerstonResearch #Collaboration #TranslationalResearch

📢Exciting Phase 1 BrCa trial @ Herston
Prof Sudha Rao & Dr Michelle Nottage — exploring the barriers & enablers to early-phase trials — from both the research & clinical perspectives💡🧪#benchtobedside #BreastCancerResearch #ClinicalTrials #Phase1Trials #Translational

A/Prof Pete Simpson shared a fantastic overview of #UQCCR’s research capacity, highlighting our strengths in #translational science, clinical partnerships & emerging technologies. A great reminder of the depth of expertise driving impact across disciplines🔬🤝 #Biobank

🏥 Phase 1 PCL breast scafford implementation one year follow-up📍
Prof Owen Ung from the #MNHHS Breast Cancer Institute with a vision for an integrated #breastcancer ecosystem across #Herston
🔬#BreastCancerCare #Collaboration #PatientCentredResearch

🔍Prof @julietfrench.bsky.social ch01 gave an insightful overview of @QIMRBerghofer’s #breastcancer research capacity, showcasing strengths in genomics, multi-omics, AI precision oncology & TME research. Exciting to see the synergy across #Herston’s research ecosystem!💡🧬 #Collaboration

🏥Dr Melissa Eastgate from RBWH Cancer Care Services highlighted the clinical strengths & research collaborations driving #breastcancer care at #Herston.
A powerful reminder of the critical link between research & real-world patient impact💗 #ClinicalImpact #TranslationalResearch

💬 In the Q&A panel, everyone emphasised the need for clear strategy & shared goals to drive meaningful collaboration across the #Herston #breastcancer ecosystem. Stronger together—for better science and better outcomes💡🤝
Thank you to all the speakers 👏

Kicking off DNA extraction for the ctDNA lobular breast cancer project — part of Tivya's PhD! Can’t wait to see what secrets these tumours are hiding…

#LabLife #LobularBreastCancer #ctDNA #PhDLife #TeamScience #UQCCR

ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selection - PubMed Assessment of ROS1 status in breast cancer appears to be highly antibody clone-dependent. ROS1 antibody clone selection will be an important consideration in the design of clinical trials investigatin...

🚨Just in from our lab!

The🗝️ to efficiently implementing targeted therapies is a robust #biomarker and our work shows this is tricky for ROS1 in #breastcancer ⤵️

📖 pubmed.ncbi.nlm.nih.gov/40356444/ @histo-journal.bsky.social

#BreastCancer #Pathology #Biomarkers #UQCCR

🍎Breast cancer... and apples?🍏@amymccart.bsky.social nailed her @pintofscienceAU talk with the perfect mix of science & analogies — a full house at Easy Times! Huge thanks to @MehershadW for hosting such a fun and insightful night! 👏🧠💥 #Pint2025 #UQCCR

Exciting news – @amymccart.bsky.social is speaking at @pintofscienceAU! 🎤👏

🗓️ Tues 20 May
📍 Easy Times Brewing Co, Brisbane
🧬 Cuts, Cures & the Stories Behind the Scars

Science, beer & good vibes – let’s go support her! 🍺

🎟️👉 pintofscience.com.au/event/cuts-c...
#pintofscience #PintAU25

Big crowd at the #10xOmiX event in Brisbane to hear from the best local scientists on how @10xgenomics.bsky.social is helping them advance their research projects.

Peer reviewer fatigue, or peer reviewer refusal? Peer review processes are slowing. Existing literature and policies conceptualize this stagnation in peer review as a result of academic fatigue. Here, we instead examine an under-researched factor...

📝 Latest Publication Alert! 📝

Commentary: Peer reviewer fatigue, or peer reviewer refusal?

Kate Beecher Matthews & Joshua Wang

→ doi.org/10.1080/0898...

#PeerReview
#ScholarlyPublishing
#ResearchIntegrity

🚨New Commentary Alert!🚨

Peer review is slowing—but is academic fatigue the only reason?🤔Are these refusals a necessary stand or a threat to scholarly publishing? ⤵️

🔗https://www.tandfonline.com/doi/full/10.1080/08989621.2025.2463977

#PeerReview #AcademicPublishing @accountabilityair.bsky.social